Electromagnetic Field Versus Diclofenac Drugs on Primary Dysmenorrhea

Cairo University (CU)

Status: Completed

Conditions: Electromagnetic Field; Dysmenorrhea

Treatments: Diagnostic Test: Menstrual symptom questionnaire; Diagnostic Test: Visual analogue scale; Device: Pulsed electromagnetic field; Diagnostic Test: Progesterone blood level; Drug: diclofenac tablets

Study type: Interventional

Funder types: Other

Identifiers

NCT03269591

dr ghada

Details and patient eligibility

About

Electromagnetic field versus diclofenac drugs on primary dysmenorrhea: Arandomized controlled trial in the Egyptian women

Full description

Background: Primary dysmenorrhea is one of the most common complaints of women and is also the most common gynecological problem worldwide. These cramps are recurrent and 90% adolescent girls and about 50% women suffer from it. Purpose of the study: to determine which is more effective in alleviating primary dysmenorrhea; pulsed electromagnetic field or diclofenac drugs. Methodology: The study was a randomized, double-blinded trial, fifty adult females participated in this study, were divided randomly into two groups equal in numbers: group (A) received pulsed electromagnetic field applied on pelvic region, 3 times per week for 3 months, 20 minutes per day and group (B) received diclofenac tablets, 50 mg only with onset of menstrual pain. All participants in both groups (A and B) were assessed pre- and post-treatment through measuring progesterone level in the blood, assessment of pain using visual analogue scale and physical as well as psychological symptoms by using menstrual symptom questionnaire.

Enrollment: 50 patients

Sex: Female

Ages: 17 to 24 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

-regular menstrual cycle 21-35 days lasting 3-7 days

Exclusion criteria

• Irregulars or infrequent menstrual cycles, Pacemaker, Myasthenia gravis, hyperthyroidism, active tuberculosis and psychosis

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

50 participants in 5 patient groups

Pulsed electromagnetic field

Active Comparator group

Description:

magnetic therapy device which generate frequency from 5-100 Hz and intensity from 1 to 60 Gauss. Group (A) received 20 min 3 times per week for three month with strength 60 gauss and frequency 50 Hz

Treatment:

Diagnostic Test: Menstrual symptom questionnaire

Diagnostic Test: Progesterone blood level

Diagnostic Test: Visual analogue scale

Drug: diclofenac tablets

Device: Pulsed electromagnetic field

diclofenac tablets

Experimental group

Description:

(50 mg) few hours at the onset of menstruation for 3 months

Treatment:

Diagnostic Test: Menstrual symptom questionnaire

Diagnostic Test: Progesterone blood level

Diagnostic Test: Visual analogue scale

Drug: diclofenac tablets

Device: Pulsed electromagnetic field

Visual analogue scale

Other group

Description:

was used to determine the pain intensity level. Pain assessed before and after treatment procedure (3 month)

Treatment:

Diagnostic Test: Menstrual symptom questionnaire

Diagnostic Test: Progesterone blood level

Diagnostic Test: Visual analogue scale

Drug: diclofenac tablets

Device: Pulsed electromagnetic field

Progesterone blood level

Other group

Description:

Sample of blood was taken to detect the level of progesterone.

Treatment:

Diagnostic Test: Menstrual symptom questionnaire

Diagnostic Test: Progesterone blood level

Diagnostic Test: Visual analogue scale

Drug: diclofenac tablets

Device: Pulsed electromagnetic field

Menstrual symptom questionnaire

Other group

Description:

to assess symptoms of dysmenorrhea.

Treatment:

Diagnostic Test: Menstrual symptom questionnaire

Diagnostic Test: Progesterone blood level

Diagnostic Test: Visual analogue scale

Drug: diclofenac tablets

Device: Pulsed electromagnetic field